Endava plc (DAVA) Alert: Securities Fraud Class Action Filed, Investors with Losses Encouraged to Contact Hagens Berman

Endava shares fell more than 25% on September 22, 2026, after the company disclosed an internal accounting investigation, placed CFO Mark Thurston on administrative leave, appointed an interim CFO, and delayed its quarterly and annual reports. Hagens Berman says it is investigating a securities class action alleging Endava failed to disclose accounting-review issues involving certain customer and supplier agreements and potential risks to its statements about its AI pivot; the allegations have not been established. The lead-plaintiff deadline is November 30, 2026.

Analysis

The key risk is not the class action itself; it is the unresolved accounting review and delayed reporting. A restatement or prolonged control failure could raise the discount investors apply to reported growth and cash conversion, while also weakening confidence in management’s AI positioning. The alleged accounting issues concern certain customer and supplier agreements, so the scope and financial effect remain unknown: do not assume either broad revenue inflation or that AI demand is fictitious. The lawsuit is plaintiff-firm marketing, and its allegations are not findings.

In the next several weeks, the decisive catalysts are the filing timetable, auditor conclusions, and whether management quantifies adjustments or identifies control deficiencies. Over 1–3 months, any restatement, auditor qualification, or further leadership disruption could keep DAVA under pressure and make customers more cautious about contract continuity. Over 6–18 months, the durable question is whether the issue is confined to accounting treatment or reveals weaker underlying growth and execution. Consulting competitors such as Accenture, Globant, and EPAM could benefit at the margin if clients shift work, but there is no evidence yet of customer transfers.

Contrarian point: the lawsuit headline adds little incremental information after the sharp selloff; the independent audit concern and reporting uncertainty are the substantive overhang. Without valuation, positioning, or options data, it is not possible to call the selloff excessive or quantify short-side upside.

Key Decisions for Investors

• Avoid fresh unhedged DAVA exposure until the company provides a credible reporting timetable and the auditor review clarifies the scope. Treat the November 30 lead-plaintiff deadline as a legal-process date, not a fundamental catalyst.
• Event-driven investors may consider a small, defined-risk bearish position only if filings remain delayed or management confirms a material restatement/control weakness; assess option pricing first, since elevated implied volatility could make puts unattractive. Do not short solely on the class-action announcement.
• For relative exposure, consider underweighting DAVA versus a diversified IT-services peer basket, including Accenture, Globant, and EPAM, while recognizing that any substitution benefit is hypothetical until customer or pipeline evidence appears.
• Reassess on the next company update: a quantified, limited adjustment, timely filings, and no evidence of impaired customer relationships would weaken the bearish thesis. A broader restatement, auditor qualification, further delay, or downward revision to operating guidance would strengthen it.